Derma Sciences, Inc. (Nasdaq: DSCI) announces receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company's patent-pending MEDIHONEY® Gel Wound and Burn Dressing. This latest MEDIHONEY line extension is dispensed from a tube and is comprised of Active Manuka (Leptospermum) honey blended with natural-based gelling agents.
According to the company, MEDIHONEY Gel will provide clinicians and patients with added versatility in their use of honey-based products for challenging wounds and burns. Because the product is blended with gelling agents, the honey is able to maintain its physical integrity at the site of the wound, even in the presence of wound fluid and body heat.
For more information, visit www.dermasciences.com